Paul Howard

Statistics

Publications

Citations

271

H-Index

Active since

2003

Affiliations

Pfizer (United States)(Current)

Paul Howard is an author at Pfizer (United States) specializing in pharmacoeconomics, model-based economic evaluation, and pharmacoeconomic evaluation.

Publications per year

2003–2016

Publications

Cost-Utility Analysis of Varenicline versus Existing Smoking Cessation Strategies using the BENESCO Simulation Model

Paul Howard, Christopher P. Knight, Annabel Boler et al. · PharmacoEconomics · 2008 · 99 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16

Homelessness, Unsheltered Status, and Risk Factors for Mortality

Ann Elizabeth Montgomery, Dorota Szymkowiak, Jessica Marcus et al. · Public Health Reports · 2016 · 96 citations · Full text

Public Health, Community Health, Population Health Sciences +17

The Cost-Effectiveness of an Extended Course (12 + 12 Weeks) of Varenicline Compared with Other Available Smoking Cessation Strategies in the United States: An Extension and Update to the BENESCO Model

Paul Howard, Christine L. Baker, Jenő P. Marton · Value in Health · 2009 · 59 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

Equity, Access and Economic Evaluation in Rare Diseases

Nick Bosanquet, Gianfranco Domenighetti, Ariel Béresniak et al. · Pharmaceutical Development and Regulation · 2003 · 17 citations

Social Sciences, Economics, Pharmacoeconomics +14

1–4 of 4